On the use of Fuzailov’s informational preparation “MR-anti-protein-blocker“
AUTHORS : Fuzailov B.N. | Makina S.K.
RELEVANT UNIVERSITIES : Moscow, Russia; Petropavlovsk, Kazakhstan
YEAR : 2007
In the collections of materials of international conferences “Theoretical and clinical aspects of the use of bioresonance and multiresonant therapy” (2002-2006), reports of BN Fuzailov, MM Shraibman are published. on the relevance of testing and the use of the drug Fuzailova (PF) “MR-antiprotein-
blocker” in cancer patients. According to the hypothesis of B.N. “About a single mechanism of cancer cell nucleation”, pathological cells are ready for unrestrained growth, from the moment of incorporation of a specific complex highly polar compound “MP-protein” into the genetic apparatus of
the cell and activates a certain gene (gene of a pure cancer line in the family tree). Which, in turn, triggers the synthesis of a new protein corresponding to this gene. The oncological process is almost always preceded by a pathological change in cells,